Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study

G Tang, JK Sydney Sir Philip, O Weinberg, W Tam… - Modern …, 2019 - nature.com
The purpose of this study is to examine hematopoietic neoplasms with 9p24/JAK2
rearrangement including neoplasms associated with t (8; 9)(p22; p24)/PCM1-JAK2 fusion …

8p11 Myeloproliferative syndrome with BCR-FGFR1 rearrangement presenting with T-lymphoblastic lymphoma and bone marrow stromal cell proliferation: a case …

SY Kim, B Oh, CJ She, HK Kim, YK Jeon, MG Shin… - Leukemia Research, 2011 - Elsevier
Discussion The FGFR1 has a number of fusion partners, including ZNF198, CEP110,
FGFR1OP1, BCR, TRIM24, MYO18A, HERVK, FGFR1OP2, CPSF6, and LRRFIP1 [4]. Unlike …

[HTML][HTML] Molecular alterations underlying eosinophilic and mast cell malignancies

H Sadrzadeh, O Abdel-Wahab… - Discovery …, 2011 - discoverymedicine.com
Eosinophilic and mast cell disorders are uncommon hematologic entities, but they can carry
significant morbidity and lead to devastating end-organ sequelae. In the past ten years …

A rare case report of 8p11 myeloid and lymphoid neoplasm with FGFR1 abnormality in a young adult

H Shaaban, J Dabu, K Al-Rabi, D Gauchan… - Annals of …, 2013 - Springer
Dear Editor, The 8p11 myeloproliferative syndrome is now classified by the World Health
Organization as myeloid and lymphoid neoplasm with fibroblast growth factor receptor 1 …

[引用][C] Strike three for the 8p11–an illustrative case of variable clinical presentations in a patient with myeloid/lymphoid neoplasms with FGFR1 rearrangement

C Rice, P Cannell, R De Kraa, M Wright… - …, 2024 - pathologyjournal.rcpa.edu.au
Discussion: Myeloid/lymphoid neoplasm with FGFR1 rearrangement has a spectrum of
clinical presentations. This case highlights the importance of cytogenetic analyses in …